Satish Muluk, MD
Surgical Critical Care · Pittsburgh, PANPI 1659372043
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Boston Scientific at 49.5% of the total. 2025 is the largest year on record at $12,188, 2.7 times the $4,502 reported in 2019. Among surgical critical care clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $294.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$16K
- Medtronic$6K
- Silk Road Medical, Inc.$5K
- Endologix LLC$3K
- Cook Medical LLC$565
- Centerline Biomedical Inc.$484
- plus $822 from 10 others
Across 93 payments — averaging $2604.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$156K
- Silk Road Medical, Inc.$48K
- Cook Research Incorporated$22K
- Medtronic$9K
- Boston Scientific$7K
What the payments were for
- Consulting fees$17,60056%
- Speaking & faculty fees$2,2007%
- Travel & lodging$3,70512%
- Food & beverage$8,03625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 29 | $15,625 |
| Medtronic(2 entities) | 21 | $6,262 |
| Silk Road Medical, Inc. | 18 | $5,008 |
| Endologix LLC | 14 | $2,774 |
| Cook Medical LLC | 6 | $565 |
| Centerline Biomedical Inc. | 5 | $484 |
| Terumo Medical Corporation | 2 | $275 |
| Shape Memory Medical Inc. | 2 | $228 |
| Bard Peripheral Vascular, Inc. | 2 | $120 |
| Abbott | 2 | $67 |
| Johnson & Johnson | 1 | $37 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Pfizer | 1 | $19 |
| Lemaitre Vascular, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Cagent Vascular Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$7,783
- ENROUTE Transcarotid Neuroprotection System$5,141
- ENHANCE Transcarotid Peripheral Access Kit$4,358
- ENROUTE Transcarotid Stent System$3,884
- ENROUTE 0.014 Guidewire$3,884
- Heli-FX EndoAnchor System$2,200
- Endurant$1,344
- Alto Abdominal Stent Graft System$1,134
- ENROUTE Transcarotid Stent$953
- ENDURANT IIS$872
- IOPS$870
- ENROUTE .014 Guidewire$475
- IOPS MOBILE CART$421
- AFX2 Bifurcated Endograft System$400
- IOPS SOFTWARE APPLICATION$290
- GENERAL VASCULAR ACCESS$281
- Torus Stent Graft System$274
- ENDOCROSS Device$274
- Zilver PTX$254
- IMPEDE EMBOLIZATION PLUG$228
How this compares
$31,541 in reported general payments places this provider in the 95th percentile of 124 surgical critical care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $32,405 |
| XareltoRivaroxaban | 22 | $26,595 |
| ClopidogrelClopidogrel Bisulfate | 107 | $1,142 |
| Atorvastatin Calcium | 36 | $616 |
| Cilostazol | 44 | $499 |
| Gabapentin | 43 | $398 |
| Ezetimibe | 12 | $29 |
| Prednisone | 16 | $9 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $32,40539 claims |
| Johnson & JohnsonXarelto | $37 | $26,59522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 124 surgical critical care providers in Pennsylvania.
Other surgical critical care in Pittsburgh
- Alan MurdockPittsburgh$32K
- Jason BreggPittsburgh$9K
- Uzer KhanPittsburgh$6K
- Akhtar KhanPittsburgh$6K
- Gary ZhangPittsburgh$5K
- Jonathan ChicaPittsburgh$5K
- Heather HoopsPittsburgh$4K
- Amy CoheePittsburgh$3K
- Moheb SaidPittsburgh$3K
- Jennifer ChenPittsburgh$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.